CAPN3 mutations in patients with idiopathic eosinophilic myositis.
about
Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degenerationEosinophils in hereditary and inflammatory myopathies.Gene expression profiling in limb-girdle muscular dystrophy 2AGenome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease.Eosinophils: changing perspectives in health and disease.Severe Rhabdomyolysis without Systemic Involvement: A Rare Case of Idiopathic Eosinophilic Polymyositis.Clinical and Pathological Heterogeneity of Korean Patients with CAPN3 MutationsImpaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.Congenital muscular dystrophy with inflammation: Diagnostic considerations.Induction of muscle weakness by local inflammation: an experimental animal model.Review: An update on inflammatory and autoimmune myopathies.Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls.The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment.Multisystem Disease, Including Eosinophilia and Progressive Hyper-Creatine-Kinase-emia over 10 Years, Suggests Mitochondrial Disorder.How to tackle the diagnosis of limb-girdle muscular dystrophy 2ALimb-girdle muscular dystrophy type 2A in Brazilian children.Entire CAPN3 gene deletion in a patient with limb-girdle muscular dystrophy type 2A.Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy.Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.
P2860
Q24300646-9DDA196D-E448-4B8B-8138-C07D96DFBBB0Q30317451-97932CC2-CE3A-4669-BBE3-C6BF4D40B71CQ33385149-D8363CAE-7E8A-4699-B001-8D9695711484Q34003041-2BD4D2C3-7C00-449C-A50A-2D14ED75DBB3Q35170969-E76F6B81-7181-4B46-B198-69751BABB176Q35851762-BEEA7A08-43E5-4254-BCBC-5A0B3A631558Q36418689-6FFC88E2-7ACB-4F05-8353-1B5E0C019D6BQ36791425-C130DCF6-B007-4338-A5F5-86B691F7A433Q37039715-BD587D31-8D31-4471-964A-C46905AA3227Q37167371-EE0482D7-C03A-4164-8A17-85188F72B484Q37467294-77F2E910-1000-408B-9490-9830E6E7DA11Q37820692-1694FA37-3E46-4867-8FA4-FF89890363D8Q38434135-FC2A95A4-AB01-43D4-9876-CD68021CDD2BQ38700961-67168E1F-4041-45B4-944F-4E92F69D6AEEQ40961367-F0E99C9E-9E4B-4017-86FF-AF77C1A7F22EQ42146380-D14DFFD6-274C-443B-B570-334F60A361CDQ42271189-BB96865C-EDE7-4687-AE38-8CB36AD789ABQ50950676-304B59B6-BF2D-462E-9EC1-01B4BE030583Q51742869-09425D62-BBE9-496E-88DC-8F3EAE47DC35Q54121876-865F0738-F82B-4EDB-AA1F-00631E949261Q54528213-9431DD40-BE52-428E-9206-FDF912E5BD6E
P2860
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@en
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@nl
type
label
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@en
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@nl
prefLabel
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@en
CAPN3 mutations in patients with idiopathic eosinophilic myositis.
@nl
P2093
P50
P356
P1433
P1476
CAPN3 mutations in patients with idiopathic eosinophilic myositis
@en
P2093
Ana Cabello
Christophe Pécheux
Eugenia Yoldi
Federico Garcia-Bragado
France Leturcq
Hervé Testard
J Andoni Urtizberea
José L Pena-Segura
Juan J Poza
Martin Krahn
P2860
P304
P356
10.1002/ANA.20833
P577
2006-06-01T00:00:00Z